RMD - Guggenheim likes Seattle Genetics in premarket analyst action May, 01 2020 07:42 AM ResMed Inc. Axcella Health (NASDAQ:AXLA) initiated with Buy rating and $10 (115% upside) price target at BTIG Research.More news on: Axcella Health Inc., Viking Therapeutics, Inc., Y-mAbs Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more ...